Dr. Jennifer MacDiarmid and Dr. Himanshu Brahmbhatt are the co-founders of EnGeneIC, a biopharmaceutical company known for its innovative EDV technology.

Dr. MacDiarmid, who grew up on a sheep farm in Sydney, developed an early passion for science through hands-on experiments with her father. She pursued molecular biology, earning her M.Sc and Ph.D. from the University of New South Wales.

Dr. Brahmbhatt, originally from Kenya, faced numerous health challenges before completing his education and postdoctoral research in Australia, Germany, and Switzerland.

Their paths converged at CSIRO, where their shared vision for advancing medical science led them to establish EnGeneIC. Despite initial challenges and limited support, their dedication resulted in the development of EDV technology, a novel approach to cancer treatment. Their journey highlights their commitment to improving patient outcomes and addressing global health challenges.